跳至主要内容
临床试验/NCT04972383
NCT04972383已完成3 期

A Prospective,Double-Blind Randomized Controlled Trial Comparing Effect of Autologous Platelet-Rich Plasma Versus Hyaluronic Acid Treatment on Progression of Structural Changes in Knee Osteoarthritis

Kaohsiung Medical University Chung-Ho Memorial Hospital2 个研究点 分布在 1 个国家目标入组 116 人开始时间: 2017年11月7日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
116
试验地点
2
主要终点
The change of Western Ontario and McMaster Universities Index (WOMAC) score from baseline

研究概览

简要总结

To compare the efficacy and structural change of intraarticular single platelet-rich plasma(PRP) versus novel crosslinked Hyaluronic Acid(HA)(HyajointPlus) for the treatment of early stage knee osteoarthritis(OA). This was a prospective, double-blind, RCT with an allocation ratio of 1:1.

详细描述

In the PRP group, an Aeon Acti-PRP set was used and an approximately 4-mL PRP volume was yielded and was used in a single-dose treatment. In the HA group, HYAJOINT Plus containing 60 mg of purified sodium hyaluronate was used in a single-dose treatment. All PRP and HA injection syringes were covered with opaque envelop, and the intra-articular injection procedure was performed by the same physician without ultrasound or other imaging guidance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients older than 50 years
  • a diagnosis of primary knee osteoarthritis
  • Kellgren-Lawrence (K-L) grading scale smaller than 3
  • both male and female.

排除标准

  • patients younger than 50 years of age
  • K-L grade 3 or more
  • history or active presence of clinically significant inflammatory articular or rheumatic disease other than OA
  • generalized OA
  • the detection of rapidly progressive OA before the start of the trial
  • underwent any previous lower extremity surgery
  • excessive mechanical axis deviation (varus > 5°, valgus > 5°)
  • body mass index larger than 30
  • history or presence of malignant disorders
  • systemic disorders such as diabetes mellitus, severe cardiovascular diseases, hematologic diseases, immune-deficiencies, and infections
  • systematic or intra-articular corticosteroid therapy in the previous 3 months
  • prior treatment with HA in the past 6 months
  • anticoagulants or antiaggregants therapy in the preceding 30 days
  • non-steroidal anti-inflammatory medications in the preceding 7 days
  • platelet count less than 150,000/ml of blood
  • hemoglobin values less than 12g/dL of blood.

结局指标

主要结局

The change of Western Ontario and McMaster Universities Index (WOMAC) score from baseline

时间窗: Baseline and 1-month, 3-month, 6-month after injection

The minimum value of Western Ontario and McMaster Universities Index (WOMAC) score is zero and the maximum is 96, whether higher scores mean a worse outcome.

次要结局

  • The change of Knee Cartilage strain ratio from baseline(Baseline and 1-month, 3-month, 6-month after injection)
  • The change of Knee Cartilage Grading System from baseline(Baseline and 1-month, 3-month, 6-month after injection)
  • The change of MRI Osteoarthritis Knee Score (MOAKS) from baseline(Baseline and 6-month after injection)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验